---
title: "Amaros AI: AI platform turning ophthalmology clinical data into insights for trials, RWE and commercial teams"
url: https://emrr.uz/amaros?lang=uz
language: uz
updated: 2026-11-18T13:47:10Z
source: emrr (https://emrr.uz)
---

# Amaros AI

AI platform turning ophthalmology clinical data into insights for trials, RWE and commercial teams

[amaros.ai](https://amaros.ai/)

- **Soha**: HealthTech, AI / ML
- **Tashkil etilgan**: 2019
- **Joylashuv**: United States

## Tasdiqlangan daromad: hali ulanmagan

Amaros AI sizningmi? Ushbu sahifani soʻrang va Stripe, App Store yoki Google Play’ni ulang: MRR va oʻsishingiz shu yerda toʻgʻridan-toʻgʻri manbadan koʻrinadi.

[Sizniki boʻlsa, soʻrang](https://panel.emrr.uz/reserve/amaros)

## Startap haqida

Amaros AI builds AmarosEngine, an AI platform for ophthalmology. It combines EMRs, imaging, genetics, provider notes and payer claims into structured insights for clinical trials, real-world evidence and commercial teams. It was founded in 2019 in Silicon Valley, US, and is backed by Armenia-based SmartGate VC.

## Jamoa

- **Vartan Ghazarossian**, Co-founder and CEO (Asoschi)
- **Ben Toker**, Co-founder and President (Asoschi)

## Auditoriya

Ijtimoiy tarmoqlardagi kuzatuvchilar

- [X @amarosai_](https://x.com/amarosai_)
- [LinkedIn amaros-ai](https://www.linkedin.com/company/amaros-ai/)

Profil maʼlumotlari manbasi: Stanbase.

2026-yil 18-noyabr yangilangan

[Bu sahifa Markdown formatida](https://emrr.uz/amaros.md?lang=uz)

[Tasdiqlangan sahifa ochish](https://emrr.uz/?lang=uz): Stripe, App Store yoki Google Play’ni ikki daqiqada ulang va xuddi shunday sahifaga ega boʻling. emrr har bir raqamni oʻzi oʻqiydi, shuning uchun investorlar raqamlaringizga ishonishi mumkin. $1,000 MRR’gacha bepul.
